Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	79	111.7	642.6	576.3	621.5	168
Cash & Cash Equivalents	79	111.7	642.6	576.3	621.5	168
Cash Growth	-81.64%	-82.62%	11.50%	-7.27%	269.94%	49.47%
Receivables	233.5	191	159.2	278.9	230.9	270.7
Inventory	333.4	328.9	350.7	344.5	307	222.5
Other Current Assets	36.5	47.9	57.9	70.2	36.5	25
Total Current Assets	682.4	679.5	1,210	1,270	1,196	686.2
Property, Plant & Equipment	379.4	382.8	817.6	800.1	644.1	542.3
Goodwill and Intangibles	550.4	566.6	947	829.5	929.8	979.5
Other Long-Term Assets	191.4	194.3	191.3	58.2	113.4	119.3
Total Long-Term Assets	1,121	1,144	1,956	1,688	1,687	1,641
Total Assets	1,804	1,823	3,166	2,958	2,883	2,327
Accounts Payable	100.2	112.2	103.5	128.9	136.1	94.8
Current Debt	459.2	413.7	957.3	31.6	33.8	12.9
Other Current Liabilities	70.8	125.4	168.1	213.5	214.6	108.6
Total Current Liabilities	630.2	651.3	1,229	374	384.5	216.3
Long-Term Debt	446.7	446.5	448.5	809.4	841	798.4
Other Long-Term Liabilities	62.8	76.1	101.2	162.8	210.7	224.1
Total Long-Term Liabilities	509.5	522.6	549.7	972.2	1,052	1,023
Total Liabilities	1,140	1,174	1,779	1,346	1,436	1,239
Total Debt	905.9	860.2	1,406	841	874.8	811.3
Debt Growth	-35.22%	-38.81%	67.16%	-3.86%	7.83%	2.10%
Retained Earnings	-12.8	-21.8	738.7	950.3	726.9	421.8
Comprehensive Income	-5.5	-5.7	3.1	-16.1	-25.3	-9.9
Shareholders' Equity	663.9	649.3	1,388	1,612	1,447	1,089
Net Cash / Debt	-826.9	-748.5	-763.2	-264.7	-253.3	-643.3
Net Cash Per Share	-15.84	-14.62	-15.23	-4.89	-4.71	-12.28
Working Capital	52.2	28.2	-18.5	895.9	811.4	469.9
Book Value Per Share	12.72	12.68	27.70	30.12	27.46	21.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).